Citius Oncology, INC. (CTOR) — DEF 14A Filings
All DEF 14A filings from Citius Oncology, INC.. Browse 2 Proxy Statement reports with AI-powered summaries and risk analysis.
DEF 14A Filings (2)
-
CTOR Seeks Share Dilution, Board Re-election at Oct. 27 Meeting
— Sep 26, 2025 Risk: medium
Citius Oncology, Inc. (CTOR) is holding its Annual Meeting on October 27, 2025, to address three key proposals. The company seeks to elect two Class I directors -
TenX Keane Acquisition Calls Extraordinary General Meeting for January 17, 2024
— Jan 8, 2024 Risk:
TenX Keane Acquisition (CTOR) filed a Proxy Statement (DEF 14A) with the SEC on January 8, 2024. TenX Keane Acquisition will hold an extraordinary general meeti
Popular Companies
AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX